Skip to main content
SpringerLink
Log in

Genes and the Environment in Neurodegeneration

  • Original Paper
  • Published:
Bioscience Reports

Abstract

Neurodegenerative diseases are a heterogeneous group of pathologies which includes complex multifactorial diseases, monogenic disorders and disorders for which inherited, sporadic and transmissible forms are known. Factors associated with predisposition and vulnerability to neurodegenerative disorders may be described usefully within the context of gene–environment interplay. There are many identified genetic determinants for neurodegeneration, and it is possible to duplicate many elements of recognized human neurodegenerative disorders in animal models of the disease. However, there are similarly several identifiable environmental influences on outcomes of the genetic defects; and the course of a progressive neurodegenerative disorder can be greatly modified by environmental elements. In this review we highlight some of the major neurodegenerative disorders (Alzheimer’s disease, Parkinson’s disease, Amyotrophic lateral sclerosis, Huntington’s disease, and prion diseases.) and discuss possible links of gene–environment interplay including, where implicated, mitochondrial genes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Abalkhail H, Mitchell J, Habgood J, Orrell R, de Belleroche J (2003) A new familial amyotrophic lateral sclerosis locus on chromosome 16q12.1–16q12.2. Am J Hum Genet 73(2):383–389

    PubMed  CAS  Google Scholar 

  • Agundez JA, Jimenez-Jimenez FJ, Luengo A, Molina JA, Orti-Pareja M, Vazquez A, Ramos F, Duarte J, Coria F, Ladero JM, Alvarez-Cermeno JC, Benitez J (1998) Slow allotypic variants of the NAT2 gene and susceptibility to early-onset Parkinson’s disease. Neurology 51:1587–1592

    PubMed  CAS  Google Scholar 

  • Arning L, Jagiello P, Wieczorek S, Saft C, Andrich J, Epplen JT (2004) Glutathione S-Transferase Omega 1 variation does not influence age at onset of Huntington’s disease. BMC Med Genet 5:7

    PubMed  Google Scholar 

  • Arning L, Kraus PH, Valentin S, Saft C, Andrich J, Epplen JT (2005) NR2A and NR2B receptor gene variations modify age at onset in Huntington disease. Neurogenetics 6(1):25–28

    PubMed  CAS  Google Scholar 

  • Assal F, Alarcon M, Solomon EC, Masterman D, Geschwind DH, Cummings JL (2004) Association of the serotonin transporter and receptor gene polymorphisms in neuropsychiatric symptoms in Alzheimer disease. Arch Neurol 61:1249–1253

    PubMed  Google Scholar 

  • Atamna H, Boyle K (2006) Amyloid-beta peptide binds with heme to form a peroxidase: relationship to the cytopathologies of Alzheimer’s disease. Proc Natl Acad Sci USA 103:3381–3386

    PubMed  CAS  Google Scholar 

  • Autere J, Autere J, Moilanen JS, Finnila S, Soininen H, Mannermaa A, Hartikainen P, Hallikainen M, Majamaa K (2004) Mitochondrial DNA polymorphisms as risk factors for Parkinson’s disease and Parkinson’s disease dementia. Hum Genet 115:29–35

    PubMed  CAS  Google Scholar 

  • Baldi I, Lebailly P, Mohammed-Brahim B, Letenneur L, Dartigues JF, Brochard P (2003) Neurodegenerative diseases and exposure to pesticides in the elderly. Am J Epidemiolf 157:409–414

    Google Scholar 

  • Beal MF (2005) Mitochondria take center stage in aging and neurodegeneration. Ann Neurol 58:495–505

    PubMed  CAS  Google Scholar 

  • Bernardini S, Bellincampi L, Ballerini S, Federici G, Iori R, Trequattrini A, Ciappi F, Baldinetti F, Bossu P, Caltagirone C, Spalletta G (2005) Glutathione S-transferase P1 *C allelic variant increases susceptibility for late-onset Alzheimer disease: association study and relationship with apolipoprotein E epsilon4 allele. Clin Chem 51:944–951

    PubMed  CAS  Google Scholar 

  • Bertram L, Blacker D, Mullin K, Keeney D, Jones J, Basu S, Yhu S, McInnis MG, Go RC, Vekrellis K, Selkoe DJ, Saunders AJ, Tanzi RE (2000) Evidence for genetic linkage of Alzheimer’s disease to chromosome 10q. Science 290:2302–2303

    PubMed  CAS  Google Scholar 

  • Borthwick GM, Taylor RW, Walls TJ, Tonska K, Taylor GA, Shaw PJ, Ince PG, Turnbull DM (2006) Motor neuron disease in a patient with a mitochondrial tRNAIle mutation. Ann Neurol 59:570–574

    PubMed  CAS  Google Scholar 

  • Bossy-Wetzel E, Schwarzenbacher R, Lipton SA (2004) Molecular pathways to neurodegeneration. Nat Med 10:S2–9

    PubMed  Google Scholar 

  • Brookes AJ, Prince JA (2005) Genetic association analysis: lessons from the study of Alzheimers disease. Mutat Res 573:152–159

    PubMed  CAS  Google Scholar 

  • Brown RC, Lockwood AH, Sonawane BR (2005) Neurodegenerative diseases: an overview of environmental risk factors. Environ Health Perspect 113:1250–1256

    PubMed  CAS  Google Scholar 

  • Bush AI (2000) Metals and neuroscience. Curr Opin Chem Biol 4:184–191

    PubMed  CAS  Google Scholar 

  • Cai H, Lin X, Xie C, Laird FM, Lai C, Wen H, Chiang HC, Shim H, Farah MH, Hoke A, Price DL, Wong PC (2005) Loss of ALS2 function is insufficient to trigger motor neuron degeneration in knock-out mice but predisposes neurons to oxidative stress. J Neurosci 25:7567–7574

    PubMed  CAS  Google Scholar 

  • Cerpa W, Varela-Nallar L, Reyes AE, Minniti AN, Inestrosa NC (2005) Is there a role for copper in neurodegenerative diseases? Mol Aspects Med 26:405–420

    PubMed  CAS  Google Scholar 

  • Cha JH, Kosinski CM, Kerner JA, Alsdorf SA, Mangiarini L, Davies SW, Penney JB, Bates GP, Young AB (1998) Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene. Proc Natl Acad Sci USA 95:6480–6485

    PubMed  CAS  Google Scholar 

  • Chan DK, Mellick GD, Buchanan DD, Hung WT, Ng PW, Woo J, Kay R (2002) Lack of association between CYP1A1 polymorphism and Parkinson’s disease in a Chinese population. J Neural Transm 109:35–39

    PubMed  CAS  Google Scholar 

  • Chance PF, Rabin BA, Ryan SG, Ding Y, Scavina M, Crain B, Griffin JW, Cornblath DR (1998) Linkage of the gene for an autosomal dominant form of juvenile amyotrophic lateral sclerosis to chromosome 9q34. Am J Hum Genet 62:633–640

    PubMed  CAS  Google Scholar 

  • Chapuis J, Tian J, Shi J, Bensemain F, Cottel D, Lendon C, Amouyel P, Mann D, Lambert JC (2006) Association study of the vascular endothelial growth factor gene with the risk of developing Alzheimer’s disease. Neurobiol Aging 27:1212–1215

    PubMed  CAS  Google Scholar 

  • Chen YZ, Bennett CL, Huynh HM, Blair IP, Puls I, Irobi J, Dierick I, Abel A, Kennerson ML, Rabin BA, Nicholson GA, Auer-Grumbach M, Wagner K, De Jonghe P, Griffin JW, Fischbeck KH, Timmerman V, Cornblath DR, Chance PF (2004) DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). Am J Hum Genet 74:1128–1135

    PubMed  CAS  Google Scholar 

  • Chio A, Benzi G, Dossena M, Mutani R, Mora G (2005) Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players. Brain 128:472–476

    PubMed  Google Scholar 

  • Cherny RA, Legg JT, McLean CA, Fairlie DP, Huang X, Atwood CS, Beyreuther K, Tanzi RE, Masters CL, Bush AI (1999) Aqueous dissolution of Alzheimer’s disease Abeta amyloid deposits by biometal depletion. J Biol Chem 274:23223–23228

    PubMed  CAS  Google Scholar 

  • Choi SI, Ju WK, Choi EK, Kim J, Lea HZ, Carp RI, Wisniewski HM, Kim YS (1998) Mitochondrial dysfunction induced by oxidative stress in the brains of hamsters infected with the 263 K scrapie agent. Acta Neuropathol (Berl) 96:279–286

    CAS  Google Scholar 

  • Clifford JJ, Drago J, Natoli AL, Wong JY, Kinsella A, Waddington JL, Vaddadi KS (2002) Essential fatty acids given from conception prevent topographies of motor deficit in a transgenic model of Huntington’s disease. Neuroscience 109:81–88

    PubMed  CAS  Google Scholar 

  • Collins S, Law MG, Fletcher A, Boyd A, Kaldor J, Masters CL (1999) Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: a case-control study. Lancet 353:693–697

    PubMed  CAS  Google Scholar 

  • Comi GP, Bordoni A, Salani S, Franceschina L, Sciacco M, Prelle A, Fortunato F, Zeviani M, Napoli L, Bresolin N, Moggio M, Ausenda CD, Taanman JW, Scarlato G (1998) Cytochrome c oxidase subunit I microdeletion in a patient with motor neuron disease. Ann Neurol 43:110–116

    PubMed  CAS  Google Scholar 

  • Coppedè F, Armani C, Bidia DD, Petrozzi L, Bonuccelli U, Migliore L (2005) Molecular implications of the human glutathione transferase A-4 gene (hGSTA4) polymorphisms in neurodegenerative diseases. Mutat Res 579:107–114

    PubMed  Google Scholar 

  • Cornett CR, Markesbery WR, Ehmann WD (1998) Imbalances of trace elements related to oxidative damage in Alzheimer’s disease brain. Neurotoxicology 19:339–345

    PubMed  CAS  Google Scholar 

  • Corral-Debrinski M, Horton T, Lott MT, Shoffner JM, McKee AC, Beal MF, Graham BH, Wallace DC (1994) Marked changes in mitochondrial DNA deletion levels in Alzheimer brains. Genomics 23:471–476

    PubMed  CAS  Google Scholar 

  • Coskun PE, Beal MF, Wallace DC (2004) Alzheimer’s brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication. Proc Natl Acad Sci USA 101:10726–10731

    PubMed  CAS  Google Scholar 

  • Cutler RG (1975) Evolution of human longevity and the genetic complexity governing aging rate. Proc Natl Acad Sci USA 72:4664–4668

    PubMed  CAS  Google Scholar 

  • Davies S, Ramsden DB (2001) Huntington’s disease. Mol Pathol 54:409–413

    PubMed  CAS  Google Scholar 

  • De Silva RHA, Khan NL, Wood NW (2000) The genetics of Parkinson’s disease. Curr Opin Genet Dev 10:292–298

    PubMed  Google Scholar 

  • Del Bo R, Scarlato M, Ghezzi S, Martinelli Boneschi F, Fenoglio C, Galbiati S, Virgilio R, Galimberti D, Galimberti G, Crimi M, Ferrarese C, Scarpini E, Bresolin N, Comi GP (2005) Vascular endothelial growth factor gene variability is associated with increased risk for AD. Ann Neurol 57:373–380

    PubMed  Google Scholar 

  • Doraiswamy PM, Finefrock AE (2004) Metals in our minds: therapeutic implications for neurodegenerative disorders. Lancet Neurol 3:431–434

    PubMed  CAS  Google Scholar 

  • Drory VE, Birnbaum M, Korczyn AD, Chapman J (2001) Association of APOE epsilon4 allele with survival in amyotrophic lateral sclerosis. J Neurol Sci 190:17–20

    PubMed  CAS  Google Scholar 

  • Eaton BA, Fetter RD, Davis GW (2002) Dynactin is necessary for synapse stabilization. Neuron 34:729–741

    PubMed  CAS  Google Scholar 

  • Elson JL, Herrnstadt C, Preston G, Thal L, Morris CM, Edwardson JA, Beal MF, Turnbull DM, Howell N (2006) Does the mitochondrial genome play a role in the etiology of Alzheimer’s disease? Hum Genet 12:1–14

    Google Scholar 

  • Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Risch N, van Duijn CM (1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 278:1349–1356

    PubMed  CAS  Google Scholar 

  • Felmus MT, Patten BM, Swanke L (1976) Antecedent events in amyotrophic lateral sclerosis. Neurology 26:167–172

    PubMed  CAS  Google Scholar 

  • Fernandez LL, Scheibe RM (2005) Is MTHFR polymorphism a risk factor for Alzheimer’s disease like APOE? Arq. Neuropsiquiatr 63:1–6

    Google Scholar 

  • Figlewicz DA, Krizus A, Martinoli MG, Meininger V, Dib M, Rouleau GA, Julien JP (1994) Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. Hum Mol Genet 3:1757–1761

    PubMed  CAS  Google Scholar 

  • Finlayson MH, Martin JB (1973) Cerebral lesions in familial amyotrophic lateral sclerosis and dementia. Acta Neuropathol (Berl) 26:237–246

    CAS  Google Scholar 

  • Gardian G, Vecsei L (2004) Huntington’s disease: pathomechanism and therapeutic perspectives. J Neural Transm 111:1485–1494

    PubMed  CAS  Google Scholar 

  • Gasser T, Muller-Myhsok B, Wszolek ZK, Oehlmann R, Calne DB, Bonifati V, Bereznai B, Fabrizio E, Vieregge P, Horstmann RD (1998) A susceptibility locus for Parkinson’s disease maps to chromosome 2p13. Nat Genet 18(3):262–265

    PubMed  CAS  Google Scholar 

  • Georgiou N, Bradshaw JL, Chiu E, Tudor A, O’Gorman L, Phillips JG (1999) Differential clinical and motor control function in a pair of monozygotic twins with Huntington’s disease. Mov Disord 14:320–325

    PubMed  CAS  Google Scholar 

  • Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L, Mant R, Newton P, Rooke K, Roques P, Talbot C, Pericak-Vance M, Roses A, Williamson R, Rossor M, Owen M, Hardy J (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer’s disease. Nature 349:704–706

    PubMed  CAS  Google Scholar 

  • Goddard KA, Olson JM, Payami H, van der Voet M, Kuivaniemi H, Tromp G (2004) Evidence of linkage and association on chromosome 20 for late-onset Alzheimer disease. Neurogenetics 5:121–128

    PubMed  CAS  Google Scholar 

  • Gorell JM, Johnson CC, Rybicki BA, Peterson EL, Kortsha GX, Brown GG, Richardson RJ (1997) Occupational exposures to metals as risk factors for Parkinson’s disease. Neurology 48:650–658

    PubMed  CAS  Google Scholar 

  • Gorell JM, Johnson CC, Rybicki BA, Peterson EL, Richardson RJ (1998) The risk of Parkinson’s disease with exposure to pesticides, farming, well water, and rural living. Neurology 50:1346–1350

    PubMed  CAS  Google Scholar 

  • Graves AB, Rosner D, Echeverria D, Mortimer JA, Larson EB (1998) Occupational exposures to solvents and aluminium and estimated risk of Alzheimer’s disease. Occup Environ Med 55:627–633

    PubMed  CAS  Google Scholar 

  • Gros-Louis F, Laurent S, Lopes AA, Khoris J, Meininger V, Camu W, Rouleau GA (2003) Absence of mutations in the hypoxia response element of VEGF in ALS. Muscle Nerve 28:774–775

    PubMed  Google Scholar 

  • Gros-Louis F, Lariviere R, Gowing G, Laurent S, Camu W, Bouchard JP, Meininger V, Rouleau GA, Julien JP (2004) A frameshift deletion in peripherin gene associated with amyotrophic lateral sclerosis. J Biol Chem 279:45951–45956

    PubMed  CAS  Google Scholar 

  • Gun RT, Korten AE, Jorm AF, Henderson AS, Broe GA, Creasey H, McCusker E, Mylvaganam A (1997) Occupational risk factors for Alzheimer disease: a case-control study. Alzheimer Dis Assoc Disord 11:21–27

    PubMed  CAS  Google Scholar 

  • Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, Caliendo J, Hentati A, Kwon YW, Deng HX et al (1994) Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264:1772–1775

    PubMed  CAS  Google Scholar 

  • Gusella JF, Wexler NS, Conneally PM, Naylor SL, Anderson MA, Tanzi RE, Watkins PC, Ottina K, Wallace MR, Sakaguchi AY, Young AB, Shoulson I, Bonilla E, Martin JB (1983) A polymorphic DNA marker genetically linked to Huntington’s disease. Nature 306:234–238

    PubMed  CAS  Google Scholar 

  • Gusella JF, MacDonald ME (1995) Huntington’s disease. Semin Cell Biol 6: 21–28

    PubMed  CAS  Google Scholar 

  • Hadano S, Hand CK, Osuga H, Yanagisawa Y, Otomo A, Devon RS, Miyamoto N, Showguchi-Miyata J, Okada Y, Singaraja R, Figlewicz DA, Kwiatkowski T, Hosler BA, Sagie T, Skaug J, Nasir J, Brown RH Jr, Scherer SW, Rouleau GA, Hayden MR, Ikeda JE (2001) A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nat Genet 29:166–173

    PubMed  CAS  Google Scholar 

  • Hampshire DJ, Roberts E, Crow Y, Bond J, Mubaidin A, Wriekat AL, Al-Din A, Woods CG (2001). Kufor-Rakeb syndrome, pallido-pyramidal degeneration with supranuclear upgaze paresis and dementia, maps to 1p36. J Med Genet 38:680–682

    PubMed  CAS  Google Scholar 

  • Hand CK, Khoris J, Salachas F, Gros-Louis F, Lopes AA, Mayeux-Portas V, Brewer CG, Brown RH Jr, Meininger V, Camu W, Rouleau GA (2002) A novel locus for familial amyotrophic lateral sclerosis, on chromosome 18q. Am J Hum Genet 70:251–256

    PubMed  CAS  Google Scholar 

  • Hannan AJ (2004) Molecular mediators, environmental modulators and experience-dependent synaptic dysfunction in Huntington’s disease. Acta Biochim Pol 51:415–430

    PubMed  CAS  Google Scholar 

  • Hentati A, Bejaoui K, Pericak-Vance MA, Hentati F, Speer MC, Hung WY, Figlewicz DA, Haines J, Rimmler J, Ben Hamida C, Brown RH Jr, Siddique T (1994) Linkage of recessive familial amyotrophic lateral sclerosis to chromosome 2q33–q35. Nat Genet 7:425–428

    PubMed  CAS  Google Scholar 

  • Hentati A, Ouahchi K, Pericak-Vance MA, Nijhawan D, Ahmad A, Yang Y, Rimmler J, Hung W, Schlotter B, Ahmed A, Ben Hamida M, Hentati F, Siddique T (1998) Linkage of a commoner form of recessive amyotrophic lateral sclerosis to chromosome 15q15–q22 markers. Neurogenetics 2:55–60

    PubMed  CAS  Google Scholar 

  • Hernan MA, Checkoway H, O’Brien R, Costa-Mallen P, De Vivo I, Colditz GA, Hunter DJ, Kelsey KT, Ascherio A (2002a) MAOB intron 13 and COMT codon 158 polymorphisms, cigarette smoking, and the risk of PD. Neurology 58:1381–1387

    CAS  Google Scholar 

  • Hernan MA, Takkouche B, Caamano-Isorna F, Gestal-Otero JJ (2002b) A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson’s disease. Ann Neurol 52:276–284

    Google Scholar 

  • Hicks AA, Petursson H, Jonsson T, Stefansson H, Johannsdottir HS, Sainz J, Frigge ML, Kong A, Gulcher JR, Stefansson K, Sveinbjornsdottir S (2002) A susceptibility gene for late-onset idiopathic Parkinson’s disease. Ann Neurol 52:549–555

    PubMed  CAS  Google Scholar 

  • Higuchi S, Muramatsu T, Arai H, Hayashida M, Sasaki H, Trojanowski JQ (1995) Polymorphisms of dopamine receptor and transporter genes and Parkinson’s disease. J Neural Transm Park Dis Dement Sect 10:107–113

    PubMed  CAS  Google Scholar 

  • Hosler BA, Siddique T, Sapp PC, Sailor W, Huang MC, Hossain A, Daube JR, Nance M, Fan C, Kaplan J, Hung WY, McKenna-Yasek D, Haines JL, Pericak-Vance MA, Horvitz HR, Brown RH Jr (2000) Linkage of familial amyotrophic lateral sclerosis with frontotemporal dementia to chromosome 9q21–q22. JAMA 284:1664–1669

    PubMed  CAS  Google Scholar 

  • Howell N, Elson JL, Chinnery PF, Turnbull DM (2005) mtDNA mutations and common neurodegenerative disorders. Trends Genet 21:583–586

    PubMed  CAS  Google Scholar 

  • Huang X, Chen PC, Poole C (2004) APOE-[varepsilon]2 allele associated with higher prevalence of sporadic Parkinson disease. Neurology 62:2198–2202

    PubMed  CAS  Google Scholar 

  • Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, Pickering-Brown S, Chakraverty S, Isaacs A, Grover A, Hackett J, Adamson J, Lincoln S, Dickson D, Davies P, Petersen RC, Stevens M, de Graaff E, Wauters E, van Baren J, Hillebrand M, Joosse M, Kwon JM, Nowotny P, Che LK, Norton J, Morris JC, Reed LA, Trojanowski J, Basun H, Lannfelt L, Neystat M, Fahn S, Dark F, Tannenberg T, Dodd PR, Hayward N, Kwok JB, Schofield PR, Andreadis A, Snowden J, Craufurd D, Neary D, Owen F, Oostra BA, Hardy J, Goate A, van Swieten J, Mann D, Lynch T, Heutink P (1998) Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393:702–705

    PubMed  CAS  Google Scholar 

  • Ironside JW, Head MW (2004) Variant Creutzfeldt-Jakob disease: risk of transmission by blood and blood products. Haemophilia 10(Suppl 4):64–69

    PubMed  Google Scholar 

  • Jellinger KA (2004) Traumatic brain injury as a risk factor for Alzheimer’s disease. J Neurol Neurosurg Psychiatry 75:511–512

    PubMed  CAS  Google Scholar 

  • Johnson N, Bell P, Jonovska V, Budge M, Sim E (2004) NAT gene polymorphisms and susceptibility to Alzheimer’s disease: identification of a novel NAT1 allelic variant. BMC Med Genet 5:6

    PubMed  Google Scholar 

  • Johnson RT (2005) Prion diseases. Lancet Neurol 4:635–642

    PubMed  CAS  Google Scholar 

  • Julien JP (2001) Amyotrophic lateral sclerosis. unfolding the toxicity of the misfolded. Cell 104:581–591

    PubMed  CAS  Google Scholar 

  • Kamel F, Umbach DM, Munsat TL, Shefner JM, Hu H, Sandler DP (2002) Lead exposure and amyotrophic lateral sclerosis. Epidemiology 13:311–319

    PubMed  Google Scholar 

  • Kehoe P, Krawczak M, Harper PS, Owen MJ, Jones AL (1999) Age of onset in Huntington disease: sex specific influence of apolipoprotein E genotype and normal CAG repeat length. J Med Genet 36:108–111

    PubMed  CAS  Google Scholar 

  • Kisby GE, Ellison M, Spencer PS (1992) Content of the neurotoxins cycasin (methylazoxymethanol beta-d-glucoside) and BMAA (beta-N-methylamino-l-alanine) in cycad flour prepared by Guam Chamorros. Neurology 42:1336–1340

    PubMed  CAS  Google Scholar 

  • Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, Yokochi M, Mizuno Y, Shimizu N (1998). Mutations in the Parkin gene cause autosomal recessive juvenile Parkinsonism. Nature 392: 605–608

    PubMed  CAS  Google Scholar 

  • Kruger R, Kuhn W, Muller T, Woitalla D, Graeber M, Kosel S, Przuntek H, Epplen JT, Schols L, Riess O (1998). Ala30→ Pro mutation in the gene encoding alpha–synuclein in Parkinson’s disease. Nat Genet 18:106–108

    PubMed  CAS  Google Scholar 

  • Lambrechts D, Storkebaum E, Morimoto M, Del-Favero J, Desmet F, Marklund SL, Wyns S, Thijs V, Andersson J, van Marion I, Al-Chalabi A, Bornes S, Musson R, Hansen V, Beckman L, Adolfsson R, Pall HS, Prats H, Vermeire S, Rutgeerts P, Katayama S, Awata T, Leigh N, Lang-Lazdunski L, Dewerchin M, Shaw C, Moons L, Vlietinck R, Morrison KE, Robberecht W, Van Broeckhoven C, Collen D, Andersen PM, Carmeliet P (2003) VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat Genet 34:383–394

    PubMed  CAS  Google Scholar 

  • Langston JW, Forno LS, Tetrud J, Reeves AG, Kaplan JA, Karluk D (1999) Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure. Ann Neurol 46:598–605

    PubMed  CAS  Google Scholar 

  • Le WD, Xu P, Jankovic J, Jiang H, Appel SH, Smith RG, Vassilatis DK (2003) Mutations in NR4A2 associated with familial Parkinson disease. Nat Genet 33:85–89

    PubMed  CAS  Google Scholar 

  • Leroy E, Boyer R, Auburger G, Leube B, Ulm G, Mezey E, Harta G, Brownstein MJ, Jonnalagada S, Chernova T, Dehejia A, Lavedan C, Gasser T, Steinbach PJ, Wilkinson KD, Polymeropoulous MH (1998). The ubiquitin pathway in Parkinson’s disease. Nature 395:451–452

    PubMed  CAS  Google Scholar 

  • Levy-Lahad E, Wasco W, Poorkaj P, Romano DM, Oshima J, Pettingell WH, Yu CE, Jondro PD, Schmidt SD, Wang K, Crowley AC, Fu YH, Guenette SY, Galas D, Nemens E, Wijsman EM, Bird TD, Schellenberg GD, Tanzi RE (1995) Candidate gene for the chromosome 1 familial Alzheimer’s disease locus. Science 269:973–977

    PubMed  CAS  Google Scholar 

  • Li YJ, Oliveira SA, Xu P, Martin ER, Stenger JE, Scherzer CR, Hauser MA, Scott WK, Small GW, Nance MA, Watts RL, Hubble JP, Koller WC, Pahwa R, Stern MB, Hiner BC, Jankovic J, Goetz CG, Mastaglia F, Middleton LT, Roses AD, Saunders AM, Schmechel DE, Gullans SR, Haines JL, Gilbert JR, Vance JM, Pericak-Vance MA, Hulette C, Welsh-Bohmer KA (2003) Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease. Hum Mol Genet 12:3259–3267

    PubMed  CAS  Google Scholar 

  • Li YJ, Scott WK, Zhang L, Lin PI, Oliveira SA, Skelly T, Doraiswamy MP, Welsh-Bohmer KA, Martin ER, Haines JL, Pericak-Vance MA, and Vance JM (2006) Revealing the role of glutathione S-transferase omega in age-at-onset of Alzheimer and Parkinson diseases. Neurobiol Aging 27:1087–1093

    PubMed  CAS  Google Scholar 

  • Linsell L, Cousens SN, Smith PG, Knight RS, Zeidler M, Stewart G, de Silva R, Esmonde TF, Ward HJ, Will RG (2004) A case-control study of sporadic Creutzfeldt-Jakob disease in the United Kingdom: analysis of clustering. Neurology 63:2077–2083

    PubMed  CAS  Google Scholar 

  • Liu B, Gao HM, Hong JS (2003) Parkinson’s disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation. Environ Health Perspect 111:1065–1073

    PubMed  CAS  Google Scholar 

  • Lo HS, Chen CH, Hogan EL, Kao KP, Wang V, Yan SH (1998) Genetic polymorphism and Parkinson’s disease in Taiwan: study of debrisoquine 4-hydroxylase (CYP2D6). J Neurol Sci 158:38–42

    PubMed  CAS  Google Scholar 

  • Luoma P, Melberg A, Rinne JO, Kaukonen JA, Nupponen NN, Chalmers RM, Oldfors A, Rautakorpi I, Peltonen L, Majamaa K, Somer H, Suomalainen A (2004) Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study. Lancet 364:875–882

    PubMed  CAS  Google Scholar 

  • Luthi-Carter R, Strand A, Peters NL, Solano SM, Hollingsworth ZR, Menon AS, Frey AS, Spektor BS, Penney EB, Schilling G, Ross CA, Borchelt DR, Tapscott SJ, Young AB, Cha JH, Olson JM (2000) Decreased expression of striatal signaling genes in a mouse model of Huntington’s disease. Hum Mol Genet 9:1259–1271

    PubMed  CAS  Google Scholar 

  • Luthi-Carter R, Apostol BL, Dunah AW, De John MM, Farrell LA, Bates GP, Young AB, Standaert DG, Thompson LM, Cha JH (2003) Complex alteration of NMDA receptors in transgenic Huntington’s disease mouse brain: analysis of mRNA and protein expression, plasma membrane association, interacting proteins, and phosphorylation. Neurobiol Dis 14:624–636

    PubMed  CAS  Google Scholar 

  • MacDonald ME, Vonsattel JP, Shrinidhi J, Couropmitree NN, Cupples LA, Bird ED, Gusella JF, Myers RH (1999) Evidence for the GluR6 gene associated with younger onset age of Huntington’s disease. Neurology 53:1330–1332

    PubMed  CAS  Google Scholar 

  • Majoor-Krakauer D, Willems PJ, Hofman A (2003) Genetic epidemiology of amyotrophic lateral sclerosis. Clin Genet 63:83–101

    PubMed  CAS  Google Scholar 

  • Mancuso M, Conforti FL, Rocchi A, Tessitore A, Muglia M, Tedeschi G, Panza D, Monsurrò MR, Sola P, Mandrioli J, Choub A, DelCorona A, Manca ML, Mazzei R, Sprovieri T, Filosto M, Salviati A, Valentino P, Bono F, Caracciolo M, Simone IL, La Bella V, Majorana G, Siciliano G, Murri L, Quattrone A (2004) Could mitochondrial haplogroups play a role in sporadic amyotrophic lateral sclerosis? Neurosci Lett 371:158–162

    PubMed  CAS  Google Scholar 

  • Mancuso M, Siciliano G, Filosto M, Murri L (2006) Mitochondrial dysfunction and Alzheimer’s disease: new developments. J Alz Dis 9:111–117

    Google Scholar 

  • Martyn CN, Coggon DN, Inskip H, Lacey RF, Young WF (1997) Aluminum concentrations in drinking water and risk of Alzheimer’s disease. Epidemiology 8:281–286

    PubMed  CAS  Google Scholar 

  • Mayeux R, Sano M, Chen J, Tatemichi T, Stern Y (1991) Risk of dementia in first-degree relatives of patients with Alzheimer’s disease and related disorders. Arch Neurol 48:269–273

    PubMed  CAS  Google Scholar 

  • Mayeux R (2003) Epidemiology of neurodegeneration. Annu Rev Neurosci 26:81–104

    PubMed  CAS  Google Scholar 

  • McCann SJ, Pond SM, James KM, Le Couteur DG (1997) The association between polymorphisms in the cytochrome P-450 2D6 gene and Parkinson’s disease: a case-control study and meta-analysis. J Neurol Sci 153:50–53

    PubMed  CAS  Google Scholar 

  • McCann SJ, Le Couteur DG, Green AC, Brayne C, Johnson AG, Chan D, McManus ME, Pond SM (1998) The epidemiology of Parkinson’s disease in an Australian population. Neuroepidemiology 17:310–317

    PubMed  CAS  Google Scholar 

  • McCormack AL, Thiruchelvam M, Manning-Bog AB, Thiffault C, Langston JW, Cory-Slechta DA, Di Monte DA (2002) Environmental risk factors and Parkinson’s disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat. Neurobiol Dis 10:119–127

    PubMed  CAS  Google Scholar 

  • McGuire V, Longstreth WT Jr, Nelson LM, Koepsell TD, Checkoway H, Morgan MS, van Belle G (1997) Occupational exposures and amyotrophic lateral sclerosis. A population-based case-control study. Am J Epidemiol 145:1076–1088

    PubMed  CAS  Google Scholar 

  • McLachlan DR, Bergeron C, Smith JE, Boomer D, Rifat SL (1996) Risk for neuropathologically confirmed Alzheimer’s disease and residual aluminum in municipal drinking water employing weighted residential histories. Neurology 46:401–405

    PubMed  CAS  Google Scholar 

  • Mellick GD, Buchanan DD, McCann SJ, James KM, Johnson AG, Davis DR, Liyou N, Chan D, Le Couteur DG (1999) Variations in the monoamine oxidase B (MAOB) gene are associated with Parkinson’s disease. Mov Disord 14:219–224

    PubMed  CAS  Google Scholar 

  • Menegon A, Board PG, Blackburn AC, Mellick GD, Le Couteur DG (1998) Parkinson’s disease, pesticides, and glutathione transferase polymorphisms. Lancet 352:1344–1346

    PubMed  CAS  Google Scholar 

  • Mergler D, Baldwin M (1997) Early manifestations of manganese neurotoxicity in humans: an update. Environ Res 73:92–100

    PubMed  CAS  Google Scholar 

  • Migliore L, Coppedè F (2002) Genetic and environmental factors in cancer and neurodegenerative diseases. Mutat Res 512:135–153

    PubMed  CAS  Google Scholar 

  • Migliore L, Fontana I, Trippi F, Colognato R, Coppedè F, Tognoni G, Nucciarone B, Siciliano G (2005) Oxidative DNA damage in peripheral leukocytes of mild cognitive impairment and AD patients. Neurobiol Aging 26:567–573

    PubMed  CAS  Google Scholar 

  • Morita M, Al-Chalabi A, Andersen PM, Hosler B, Sapp P, Englund E, Mitchell JE, Habgood JJ, de Belleroche J, Xi J, Jongjaroenprasert W, Horvitz HR, Gunnarsson LG, Brown RH Jr (2006) A locus on chromosome 9p confers susceptibility to ALS and frontotemporal dementia. Neurology 66:839–844

    PubMed  CAS  Google Scholar 

  • Morris MC, Evans DA, Bienias JL, Tangney CC, Bennett DA, Wilson RS, Aggarwal N, Schneider J (2003) Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol 60:940–946

    PubMed  Google Scholar 

  • Nagai M, Aoki M, Miyoshi I, Kato M, Pasinelli P, Kasai N, Brown RH Jr, Itoyama Y (2001) Rats expressing human cytosolic copper-zinc superoxide dismutase transgenes with amyotrophic lateral sclerosis: associated mutations develop motor neuron disease. J Neurosci 21:9246–9254

    PubMed  CAS  Google Scholar 

  • Nicholl DJ, Bennett P, Hiller L, Bonifati V, Vanacore N, Fabbrini G, Marconi R, Colosimo C, Lamberti P, Stocchi F, Bonuccelli U, Vieregge P, Ramsden DB, Meco G, Williams AC (1999) A study of five candidate genes in Parkinson’s disease and related neurodegenerative disorders. European Study Group on Atypical Parkinsonism. Neurology 53:1415–1421

    Google Scholar 

  • Mutter J, Naumann J, Sadaghiani C, Schneider R, Walach H (2004) Alzheimer disease: mercury as pathogenetic factor and apolipoprotein E as a moderator. Neuro Endocrinol Lett 25:331–339

    PubMed  CAS  Google Scholar 

  • Nishimura AL, Mitne-Neto M, Silva HC, Richieri-Costa A, Middleton S, Cascio D, Kok F, Oliveira JR, Gillingwater T, Webb J, Skehel P, Zatz M (2004) A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Am J Hum Genet 75(5):822–831

    PubMed  CAS  Google Scholar 

  • Oliveri RL, Annesi G, Zappia M, Civitelli D, De Marco EV, Pasqua AA, Annesi F, Spadafora P, Gambardella A, Nicoletti G, Branca D, Caracciolo M, Aguglia U, Quattrone A (2000) The dopamine D2 receptor gene is a susceptibility locus for Parkinson’s disease. Mov Disord 15:127–131

    PubMed  CAS  Google Scholar 

  • Orru S, Mascia V, Casula M, Giuressi E, Loizedda A, Carcassi C, Giagheddu M, Contu L (1999) Association of monoamine oxidase B alleles with age at onset in amyotrophic lateral sclerosis. Neuromuscul Disord 9:593–597

    PubMed  CAS  Google Scholar 

  • Otomo A, Hadano S, Okada T, Mizumura H, Kunita R, Nishijima H, Showguchi-Miyata J, Yanagisawa Y, Kohiki E, Suga E, Yasuda M, Osuga H, Nishimoto T, Narumiya S, Ikeda JE (2003) ALS2, a novel guanine nucleotide exchange factor for the small GTPase Rab5, is implicated in endosomal dynamics. Hum Mol Genet 12:1671–1687

    PubMed  CAS  Google Scholar 

  • Ozturk A, Desai PP, Minster RL, Dekosky ST, Kamboh MI (2005) Three SNPs in the GSTO1, GSTO2 and PRSS11 genes on chromosome 10 are not associated with age-at-onset of Alzheimer’s disease. Neurobiol Aging 26:1161–1165

    PubMed  CAS  Google Scholar 

  • Paisan-Ruiz C, Jain S, Evans EW, Gilks WP, Simon J, van der Brug M, Lopez de Munain A, Aparicio S, Gil AM, Khan N, Johnson J, Martinez JR, Nicholl D, Carrera IM, Pena AS, de Silva R, Lees A, Marti-Masso JF, Perez-Tur J, Wood NW, Singleton AB (2004) Cloning of the gene containing mutations that cause PARK8-linked Parkinson’s disease. Neuron 44:595–600

    PubMed  CAS  Google Scholar 

  • Palmer MS, Dryden AJ, Hughes JT, Collinge J (1991) Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature 352:340–342

    PubMed  CAS  Google Scholar 

  • Pankratz N, Nichols WC, Uniacke SK, Halter C, Rudolph A, Shults C, Conneally PM, Foroud T, the Parkinson Study Group (2003a) Significant linkage of Parkinson disease to chromosome 2q36–37. Am J Hum Genet 72:1053–1057

    CAS  Google Scholar 

  • Pankratz N, Nichols WC, Uniacke SK, Halter C, Murrell J, Rudolph A, Shults CW, Conneally PM, Foroud T, the Parkinson Study Group (2003b) Genome-wide linkage analysis and evidence of gene-by-gene interactions in a sample of 362 multiplex Parkinson disease families. Hum Mol Genet 12:2599–2608

    CAS  Google Scholar 

  • Pedersen NL, Gatz M, Berg S, Johansson B (2004) How heritable is Alzheimer’s disease late in life? Findings from Swedish twins. Ann Neurol 55:180–185

    PubMed  Google Scholar 

  • Pennetta G, Hiesinger PR, Fabian-Fine R, Meinertzhagen IA, Bellen HJ (2002) Drosophila VAP-33A directs bouton formation at neuromuscular junctions in a dosage-dependent manner. Neuron 35:291–306

    PubMed  CAS  Google Scholar 

  • Pericak-Vance MA, Bass MP, Yamaoka LH, Gaskell PC, Scott WK, Terwedow HA, Menold MM, Conneally PM, Small GW, Vance JM, Saunders AM, Roses AD (1997) Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12. JAMA 278:1237–1241

    PubMed  CAS  Google Scholar 

  • Pericak-Vance MA, Grubber J, Bailey LR, Hedges D, West S, Santoro L, Kemmerer B, Hall JL, Saunders AM, Roses AD, Small GW, Scott WK, Conneally PM, Vance JM, Haines JL (2000) Identification of novel genes in late-onset Alzheimer’s disease. Exp Gerontol 35:1343–1352

    PubMed  CAS  Google Scholar 

  • Perls T (2004) Dementia-free centenarians. Exp Gerontol 39:1587–1593

    PubMed  Google Scholar 

  • Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ED, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Iorio GD, Golbe LI, Nussbaum RL (1997). Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease. Science 276:2045–2047

    PubMed  CAS  Google Scholar 

  • Powers KM, Smith-Weller T, Franklin GM, Longstreth WT Jr, Swanson PD, Checkoway H (2003) Parkinson’s disease risks associated with dietary iron, manganese, and other nutrient intakes. Neurology 60:1761–1766

    PubMed  CAS  Google Scholar 

  • Prusiner SB (1998) Prions. Pro Natl Acad Sci USA 95:13363–13383

    CAS  Google Scholar 

  • Puls I, Jonnakuty C, LaMonte BH, Holzbaur EL, Tokito M, Mann E, Floeter MK, Bidus K, Drayna D, Oh SJ, Brown RH Jr, Ludlow CL, Fischbeck KH (2003) Mutant dynactin in motor neuron disease. Nat Genet 33:455–456

    PubMed  CAS  Google Scholar 

  • Pyle A, Foltynie T, Tiangyou W, Lambert C, Keers SM, Allcock LM, Davison J, Lewis SJ, Perry RH, Barker R, Burn DJ, Chinnery PF (2005) Mitochondrial DNA haplogroup cluster UKJT reduces the risk of PD. Ann Neurol 57:564–567

    PubMed  Google Scholar 

  • Rademakers R, Cruts M, Sleegers K, Dermaut B, Theuns J, Aulchenko Y, Weckx S, De Pooter T, Van den Broeck M, Corsmit E, De Rijk P, Del-Favero J, van Swieten J, van Duijn CM, Van Broeckhoven C (2005) Linkage and association studies identify a novel locus for Alzheimer disease at 7q36 in a Dutch population-based sample. Am J Hum Genet 77:643–652

    PubMed  CAS  Google Scholar 

  • Rainero I, Bo M, Ferrero M, Valfre W, Vaula G, Pinessi L (2004) Association between the interleukin-1alpha gene and Alzheimer’s disease: a meta-analysis. Neurobiol Aging 25:1293–1298

    PubMed  CAS  Google Scholar 

  • Reaume AG, Elliott JL, Hoffman EK, Kowall NW, Ferrante RJ, Siwek DF, Wilcox HM, Flood DG, Beal MF, Brown RH Jr, Scott RW, Snider WD (1996) Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat Genet 13:43–47

    PubMed  CAS  Google Scholar 

  • Reiner A, Dragatsis I, Zeitlin S, Goldowitz D (2003) Wild-type huntingtin plays a role in brain development and neuronal survival. Mol Neurobiol 28:259–276

    PubMed  CAS  Google Scholar 

  • Robson KJ, Lehmann DJ, Wimhurst VL, Livesey KJ, Combrinck M, Merryweather-Clarke AT, Warden DR, Smith AD (2004) Synergy between the C2 allele of transferrin and the C282Y allele of the haemochromatosis gene (HFE) as risk factors for developing Alzheimer’s disease. J Med Genet 41:261–265

    PubMed  CAS  Google Scholar 

  • Rocchi A, Micheli D, Ceravolo R, Manca ML, Tognoni G, Siciliano G, Murri L (2003) Serotoninergic polymorphisms (5-HTTLPR and 5-HT2A): association studies with psychosis in Alzheimer disease. Genet Test 7:309–314

    PubMed  CAS  Google Scholar 

  • Rocha L, Garcia C, de Mendonca A, Gil JP, Bishop DT, Lechner MC (1999) N-acetyltransferase (NAT2) genotype and susceptibility of sporadic Alzheimer’s disease. Pharmacogenetics 9:9–15

    PubMed  CAS  Google Scholar 

  • Rogaev EI, Sherrington R, Rogaeva EA, Levesque G, Ikeda M, Liang Y, Chi H, Lin C, Holman K, Tsuda T, Mar L, Sorbi S, Nacmias B, Piacentini S, Amaducci L, Chumakov I, Cohen D, Lannfelt L, Fraser PE, RommensJM, St George-Hyslop PH (1995) Familial Alzheimer’s disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer’s disease type 3 gene. Nature 376:775–778

    PubMed  CAS  Google Scholar 

  • Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O’Regan JP, Deng HX, Rahmani Z, Krizus A, McKenna-Yasek D, Cayabyab A, Gaston SM, Berger R, Tanzi RE, Halperin JJ, Herzfeldt B, Van den Bergh R, Hung W, Bird T, Deng G, Mulder DW, Smyth C, Laing NG, Soriano E, Pericak-Vance MA, Haines J, Rouleau GA, Gusella JS, Horvitz HR, Brown RH Jr (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362:59–62

    PubMed  CAS  Google Scholar 

  • Rosenberg RN (2000) The molecular and genetic basis of Alzheimer’s disease: the end of the beginning. Neurology 54:2045–2054

    PubMed  CAS  Google Scholar 

  • Salvatore M, Seeber AC, Nacmias B, Petraroli R, D’Alessandro M, Sorbi S, Pocchiari M (1995) Apolipoprotein E in sporadic and familial Creutzfeldt-Jakob disease. Neurosci Lett 199:95–98

    PubMed  CAS  Google Scholar 

  • Sapp PC, Hosler BA, McKenna-Yasek D, Chin W, Gann A, Genise H, Gorenstein J, Huang M, Sailer W, Scheffler M, Valesky M, Haines JL, Pericak-Vance M, Siddique T, Horvitz HR, Brown RH Jr (2003) Identification of two novel loci for dominantly inherited familial amyotrophic lateral sclerosis. Am J Hum Genet 73:397–403

    PubMed  CAS  Google Scholar 

  • Sato-Harada R, Okabe S, Umeyama T, Kanai Y, Hirokawa N (1996) Microtubule-associated proteins regulate microtubule function as the track for intracellular membrane organelle transports. Cell Struct Funct 21:283–295

    PubMed  CAS  Google Scholar 

  • Schapira AHV, Mann VM, Cooper JM, Dexter D, Daniel SE, Jenner P, Clark JB, Marsden CD (1990) Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson’s disease. J Neurochem 55:2142–2145

    PubMed  CAS  Google Scholar 

  • Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, Chi H, Lin C, Li G, Holman K, Tsuda T, Mar L, Foncin JF, Bruni AC, Montesi MP, Sorbi S, Rainero I, Pinessi L, Nee L, Chumakov I, Pollen D, Brookes A, Sanseau P, Polinsky RJ, Wasco W, Da Silva HAR, Haines JL, Pericak-Vance MA, Tanzi RE, Roses AD, Fraser PE, Rommens JM, St George-Hyslop PH (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimer’s disease. Nature 375:754–760

    PubMed  CAS  Google Scholar 

  • Shobab LA, Hsiung GY, Feldman HH (2005) Cholesterol in Alzheimer’s disease. Lancet Neurol 4:841–852

    PubMed  CAS  Google Scholar 

  • Shoffner JM, Brown MD, Torroni A, Lott MT, Cabell MF, Mirra SS, Beal MS, Yang CC, GearingM, Salvo R, Watts RL, Juncos JL, Hansen LA, Crain BJ, Fayad M, Reckord CL, Wallace DC (1993) Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients. Genomics 17:171–184

    PubMed  CAS  Google Scholar 

  • Siddique T, Pericak-Vance MA, Caliendo J, Hong ST, Hung WY, Kaplan J, McKenna-Yasek D, Rimmler JB, Sapp P, Saunders AM, Scott WK, Siddique N, Haines JL, Brown RH (1998) Lack of association between apolipoprotein E genotype and sporadic amyotrophic lateral sclerosis. Neurogenetics 1:213–216

    PubMed  CAS  Google Scholar 

  • Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, Hulihan M, Peuralinna T, Dutra A, Nussbaum R, Lincoln S, Crawley A, Hanson M, Maraganore D, Adler C, Cookson MR, Muenter M, Baptista M, Miller D, Blancato J, Hardy J, Gwinn-Hardy K (2003) alpha-Synuclein locus triplication causes Parkinson’s disease. Science 302:841

    PubMed  CAS  Google Scholar 

  • Simon DK, Mayeux R, Marder K, Kowall NW, Beal MF, Johns DR (2000) Mitochondrial DNA mutations in complex I and tRNA genes in Parkinson’s disease. Neurology 54:703–709

    PubMed  CAS  Google Scholar 

  • Sparkes RS, Simon M, Cohn VH, Fournier RE, Lem J, Klisak I, Heinzmann C, Blatt C, Lucero M, Mohandas T et al (1986) Assignment of the human and mouse prion protein genes to homologous chromosomes. Proc Natl Acad Sci USA 83:7358–7362

    PubMed  CAS  Google Scholar 

  • Sullivan FR, Bird ED, Alpay M, Cha JH (2001) Remotivation therapy and Huntington’s disease. J Neurosci Nurs 33:136–142

    PubMed  CAS  Google Scholar 

  • Takakubo F, Yamamoto M, Ogawa N, Yamashita Y, Mizuno Y, Kondo I (1996) Genetic association between cytochrome P450IA1 gene and susceptibility to Parkinson’s disease. J Neural Transm 103:843–849

    PubMed  CAS  Google Scholar 

  • Tanner CM, Ottman R, Goldman SM, Ellenberg J, Chan P, Mayeux R, Langston JW (1999) Parkinson disease in twins: an etiologic study. JAMA 281:341–346

    PubMed  CAS  Google Scholar 

  • Thyagarajan D, Bressman S, Bruno C, Przedborski S, Shanske S, Lynch T, Fahn S, DiMauro S (2000) A novel mitochondrial 12SrRNA point mutation in parkinsonism, deafness, and neuropathy. Ann Neurol 48:730–736

    PubMed  CAS  Google Scholar 

  • Tsui JK, Calne DB, Wang Y, Schulzer M, Marion SA (1999) Occupational risk factors in Parkinson’s disease. Can J Public Health 90:334–337

    PubMed  CAS  Google Scholar 

  • Valente EM, Abou-Sleiman PM, Caputo V, Muqit MM, Harvey K, Gispert S, Ali Z, Del Turco D, Bentivoglio AR, Healy DG, Albanese A, Nussbaum R, Gonzalez-Maldonado R, Deller T, Salvi S, Cortelli P, Gilks WP, Latchman DS, Harvey RJ, Dallapiccola B, Auburger G, Wood NW (2004) Hereditary early-onset Parkinson’s disease caused by mutations in PINK1. Science 304:1158–1160

    PubMed  CAS  Google Scholar 

  • van Dellen A, Blakemore C, Deacon R, York D, Hannan AJ (2000) Delaying the onset of Huntington’s in mice. Nature 404:721–722

    PubMed  Google Scholar 

  • van Dellen A, Grote HE, Hannan AJ (2005) Gene–environment interactions, neuronal dysfunction and pathological plasticity in Huntington’s disease. Clin Exp Pharmacol Physiol 32:1007–1019

    PubMed  Google Scholar 

  • van der Walt JM, Nicodemus KK, Martin ER, Scott WK, Nance MA, Watts RL, Hubble JP, Haines JL, Koller WC, Lyons K, Pahwa R, Stern MB, Colcher A, Hiner BC, Jankovic J, Ondo WG, Allen FH Jr, Goetz CG, Small GW, Mastaglia F, Stajich JM, McLaurin AC, Middleton LT, Scott BL, Schmechel DE, Pericak-Vance MA, Vance JM (2003). Mitochondrial polymorphisms significantly reduce the risk of Parkinson’s disease. Am J Hum Genet 72:804–811

    PubMed  Google Scholar 

  • van der Walt JM, Dementieva YA, Martin ER, Scott WK, Nicodemus KK, Kroner CC, Welsh-Bohmer KA, Saunders AM, Roses AD, Small GW, Schmechel DE, Murali Doraiswamy P, Gilbert JR, Haines JL, Vance JM, Pericak-Vance MA (2004) Analysis of European mitochondrial haplogroups with Alzheimer disease risk. Neurosci Lett 365:28–32

    PubMed  Google Scholar 

  • van Duijn CM, Dekker MC, Bonifati V, Galjaard RJ, Houwing-Duistermaat JJ, Snijders PJ, Testers L, Breedveld GJ, Horstink M, Sandkuijl LA, van Swieten JC, Oostra BA, Heutink P (2001) Park7, a novel locus for autosomal recessive early-onset parkinsonism, on chromosome 1p36. Am J Hum Genet 69:629–634

    PubMed  Google Scholar 

  • Verpillat P, Camuzat A, Hannequin D, Thomas-Anterion C, Puel M, Belliard S, Dubois B, Didic M, Lacomblez L, Moreaud O, Golfier V, Campion D, Brice A, Clerget-Darpoux F (2002) Apolipoprotein E gene in frontotemporal dementia: an association study and meta-analysis. Eur J Hum Genet 10:399–405

    PubMed  CAS  Google Scholar 

  • Wakutani Y, Kowa H, Kusumi M, Nakaso K, Yasui K, Isoe-Wada K, Yano H, Urakami K, Takeshima T, Nakashima K (2004) A haplotype of the methylenetetrahydrofolate reductase gene is protective against late-onset Alzheimer’s disease. Neurobiol Aging 25:291–294

    PubMed  CAS  Google Scholar 

  • Walsh DM, Selkoe DJ (2004) Oligomers on the brain: the emerging role of soluble protein aggregates in neurodegeneration. Protein Pept Lett 11:213–228

    PubMed  CAS  Google Scholar 

  • Wan DC, Law LK, Ip DT, Cheung WT, Ho WK, Tsim KW, Kay R, Woo J, Pang CP (1999) Lack of allelic association of dopamine D4 receptor gene polymorphisms with Parkinson’s disease in a Chinese population. Mov Disord 14:225–229

    PubMed  CAS  Google Scholar 

  • Warwick Daw E, Payami H, Nemens EJ, Nochlin D, Bird TD, Schellenberg GD, Wijsman EM (2000) The number of trait loci in late-onset Alzheimer disease. Am J Hum Genet 66:196–204

    Google Scholar 

  • Whitworth AJ, Theodore DA, Greene JC, Benes H, Wes PD, Pallanck LJ (2005) Increased glutathione S-transferase activity rescues dopaminergic neuron loss in a Drosophila model of Parkinson’s disease. Proc Natl Acad Sci U SA 102:8024–8029

    CAS  Google Scholar 

  • Wijsman EM, Daw EW, Yu CE, Payami H, Steinbart EJ, Nochlin D, Conlon EM, Bird TD, Schellenberg GD (2004) Evidence for a novel late-onset Alzheimer disease locus on chromosome 19p13.2. Am J Hum Genet 75:398–409

    PubMed  CAS  Google Scholar 

  • Yang Y, Hentati A, Deng HX, Dabbagh O, Sasaki T, Hirano M, Hung WY, Ouahchi K, Yan J, Azim AC, Cole N, Gascon G, Yagmour A, Ben-Hamida M, Pericak-Vance M, Hentati F, Siddique T (2001) The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. Nat Genet 29:160–165

    PubMed  CAS  Google Scholar 

  • Zawia NH, Basha MR (2005) Environmental risk factors and the developmental basis for Alzheimer’s disease. Rev Neurosci 16:325–337

    PubMed  CAS  Google Scholar 

  • Zerr I, Helmhold M, Poser S, Armstrong VW, Weber T (1996) Apolipoprotein E phenotype frequency and cerebrospinal fluid concentration are not associated with Creutzfeldt-Jakob disease. Arch Neurol 53:1233–1238

    PubMed  CAS  Google Scholar 

  • Zubenko GS, Hughes HB, Stiffler JS, Hurtt MR, Kaplan BB (1998) A genome survey for novel Alzheimer disease risk loci: results at 10-cM resolution. Genomics 50:121–128

    PubMed  CAS  Google Scholar 

  • Zuntar I, Kalanj-Bognar S, Topic E, Petlevski R, Stefanovic M, Demarin V (2004) The glutathione S-transferase polymorphisms in a control population and in Alzheimer’s disease patients. Clin Chem Lab Med 42:334–339

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurosciences, University of Pisa, Via Roma 67, Pisa, 56126, Italy

    Fabio Coppedè, Michelangelo Mancuso, Gabriele Siciliano & Luigi Murri

  2. Department of Human and Environmental Sciences, University of Pisa, Via S. Giuseppe 22, Pisa, 56126, Italy

    Lucia Migliore

Authors
  1. Fabio Coppedè
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michelangelo Mancuso
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gabriele Siciliano
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lucia Migliore
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Luigi Murri
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fabio Coppedè.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Coppedè, F., Mancuso, M., Siciliano, G. et al. Genes and the Environment in Neurodegeneration. Biosci Rep 26, 341–367 (2006). https://doi.org/10.1007/s10540-006-9028-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10540-006-9028-6

Keywords

Search

Navigation